Ensurge Micropower Asa · OSL:ENSU
Ensurge Micropower Asa — Q4 2025 Earnings Presentation
9 slides from Ensurge Micropower Asa's earnings presentation, Feb 23, 2026
Slide 1: Q4 Presentation: Path to Commercialization
Q4 Presentation Path to Commercialization Oslo, February 23-24 2026
Slide 2: Q4 Report: On the Path to Commercialization
February 2026 Q4 Report: On the Path to Commercialization Q4 2025 Q1 2026 CEO 100-day assessment/ End of Q1 2026: Operational foundation for Rest of 2026: Commercialization shift to product-led model • Reliable delivery Product status • Sustained partner engagement External partnerships Market outlo
Slide 3: Q4 Achievements
February 2026 Q4 Achievements First ~100 days under new CEO Commercial Product Team • Shifted focus from legacy process and • New CEO assessed team and requirements for • Signed Corning JDA and Investment Agreement. manufacturing to battery product emphasis. commercialization, resulting in new execu
Slide 4: From R&D to Product Validation
February 2026 From R&D to Product Validation • Platform validation unlocks core value • Sound fundamental physics and a strong customer pipeline underpin validation • Enables broad product roadmap: form factors, architectures, and use-cases • Organization and operating model reset • Leadership team
Slide 5: Product Status
February 2026 Product Status New Product Introduction Accomplished Today’s Focus Discovery Engineering Innovation Proof of Concept Engineering Validation Design Validation Production Validation Mass Production Initial prototype testing Technical feasibility testing Final product testing Pilot produc
Slide 6: External Partnerships
February 2026 External Partnerships Corning Joint Development Other External Agreement (JDA) Partners • Integrating Corning’s Ribbon Ceramic cathode • Progressed negotiations with major health with Ensurge’s platform. technology device manufacturer for multi-year development program. • Initial phase
Slide 7: Market Outlook
“ February 2026 “The ‘Mother of All Inventions’ is our internal code name for Market outlook Ensurge microbatteries. No other battery form has the potential to power our AI chip.” — HEALTHTECH COMPANY EXECUTIVE Competitive landscape End-use products increasingly demand smaller, safer, more powerful
Slide 8: 2026: The Year of Commercialization
February 2026 2026: The Year of Commercialization Q1 Q2-Q4 2026 Platform Validation Commercial Validation Scalability Laying operational foundation for: • Platform performance validated • Customer demand translated into • Platform-level partnerships to unlock against defined product product-led road
Slide 9: Driving to Deliver and Scale
© Ensurge Driving to Deliver and Scale